Morgan Stanley Maintains Equal-Weight on Insulet, Lowers Price Target to $208
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on Insulet (NASDAQ:PODD) and lowered the price target from $343 to $208.
August 24, 2023 | 1:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Insulet's price target has been lowered from $343 to $208 by Morgan Stanley, while maintaining an Equal-Weight rating.
The lowering of the price target by a significant amount suggests that the analyst sees less upside potential for the stock, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100